Compare Personalis Inc. Common Stock (PSNL) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Personalis Inc. Common Stock vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Personalis Inc. Common Stock trades at $15.9 (market cap $1.70B), while iShares Broad USD Investment Grade Corporate Bond trades at $48.86 (market cap $17.73B). The key difference: iShares Broad USD Investment Grade Corporate Bond is far larger — about 10.4× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and iShares Broad USD Investment Grade Corporate Bond for 46 Days on average.
| PSNL | USIG | |
|---|---|---|
Market Cap | $1.70B | $17.73B |
Volume | 3,262,398 | 2,036,622 |
Sector | Health | Fixed Income |
52-Week High | $18.38 | $52.69 |
52-Week Low | $5.04 | $48.54 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $1.52B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USIG trades at $48.84 with minimal daily movement (+0.03%). Technical indicators show a bearish trend with moving averages signaling caution, though oscillators remain neutral. The stock faces resistance at $49 across multiple levels. Recent institutional activity includes Blue Edge Capital's new $21.9 million position and Bank of New York Mellon increasing its stake by 0.9% in Q2 2026.
The outlook remains cautious due to bearish technical signals and limited fundamental data availability. Investment opportunities exist through consistent dividend payments, with three distributions scheduled for H2 2026. Key risks include market volatility and the need for clearer financial disclosures to assess valuation metrics properly.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
